The research consistently shows that moderate calorie restriction (500-750 below TDEE) produces better long-term outcomes than extreme restriction, because it preserves the metabolic rate and lean mass that determine whether you keep the weight off
Some of the noteworthy approvals in the third quarter of 2025 include the first SC version of Keytruda in the oncology setting, first-in-class agent for bronchiectasis (a chronic inflammatory lung condition), new options for hereditary angioedema and the first treatment for Barth Syndrome (a rare life-threatening pediatric disease)
Let us know via [email protected]
Semaglutide is administered via injection, which might be a dealbreaker for some
By mimicking the action of the glucagon-like peptide-1 (GLP-1), this medication sends strong signals to the brain that modulate hunger cues
As a result, some people have turned to compounding versions, which are not approved by the FDA